Scancell Holdings PLC SCLP:London Stock Exchange

RT Quote | Exchange | GBp
Last | 2:02 PM BST
9.60UNCH (UNCH)
52 week range
7.59 - 18.29
Loading...
  • Open9.60
  • Day High0.00
  • Day Low0.00
  • Prev Close9.60
  • 52 Week High18.29
  • 52 Week High Date09/20/23
  • 52 Week Low7.59
  • 52 Week Low Date09/05/23

Key Stats

  • Market Cap110.94M
  • Shares Out927.98M
  • 10 Day Average Volume381,294.89
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change-9.46

KEY STATS

  • Open9.60
  • Day High0.00
  • Day Low0.00
  • Prev Close9.60
  • 52 Week High18.29
  • 52 Week High Date09/20/23
  • 52 Week Low7.59
  • 52 Week Low Date09/05/23
  • Market Cap110.94M
  • Shares Out927.98M
  • 10 Day Average Volume381,294.89
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change-9.46

RATIOS/PROFITABILITY

  • EPS (TTM)-1.38
  • P/E (TTM)-6.96
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Scancell Holdings PLC

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Scancell Holdings plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is a developer of immunotherapies for the treatment of cancer and infectious diseases. The Company is building a pipeline of products by utilizing its four technology platforms: Moditope and ImmunoBody for vaccines and GlyMab and AvidiMab for antibodies. Its products pipeline includes Modi-1, Modi-2, SCIB1 & iSCIB1+, SCIB2 & iSCIB2, SCOV1 and SCOV2 (COVIDITY), as well as...
Jean-Michel Cossery Ph.D.
Non-Executive Chairman of the Board
Lindy Durrant
Chief Executive Officer, Chief Scientific Officer, Executive Director
Sathijeevan Nirmalananthan
Chief Financial Officer, Executive Director
Address
Unit 202 Bellhouse Building
Sanders Road, Oxford Science Park
Oxford
OX4 4GD
United Kingdom